Increased expression of flotillin-2 protein as a novel biomarker for lymph node metastasis in nasopharyngeal carcinoma

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Wen, Qiuyuan ^a   Li, Jiao ^a   Wang, Weiyuan ^a   Xie, Guiyuan ^a   Xu, Lina ^a   Luo, Jiadi ^a   Chu, Shuzhou ^a   She, Lei ^a   Li, Duo ^a   Huang, Donghai ^b   Fan, Songqing ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FLOTILLIN 2; TUMOR MARKER; BIOLOGICAL MARKER; FLOTILLINS; MEMBRANE PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPITHELIUM HYPERPLASIA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; NOSE MUCOSA; OVERALL SURVIVAL; PREDICTIVE VALUE; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY; COMPLICATION; LYMPHATIC METASTASIS; METABOLISM; MIDDLE AGED; NASOPHARYNX TUMOR; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; YOUNG ADULT;

EID: 84904270213     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101676     Document Type: Article

References (28)

1. Cho WC (2007) Nasopharyngeal carcinoma: molecular biomarker discovery and progress. Mol Cancer 6:1.
2. Chou J, Lin YC, Kim J, You L, Xu Z, et al. (2008) Nasopharyngeal carcinoma - review of the molecular mechanisms of tumorigenesis. Head Neck 30: 946-963. (Pubitemid 352008957)
3. Sham JS, Choy D, Wei WI (1990) Nasopharyngeal carcinoma: orderly neck node spread. Int J Radiat Oncol Biol Phys. 19: 929-933. (Pubitemid 20345161)
4. Tavernarakis N, Driscoll M, Kyrpides NC (1999) The SPFH domain: implicated in regulating targeted protein turnover in stomatins and other membrane-associated proteins. Trends Biochem Sci 24: 425-427. (Pubitemid 29528200)
5. Hazarika P, Dham N, Patel P, Cho M, Weidner D, et al. (1999) Flotillin 2 is distinct from epidermal surface antigen (ESA) and is associated with filopodia formation. J Cell Biochem. 75: 147-159. (Pubitemid 29402553)
6. Hazarika P, McCarty MF, Prieto VG, George S, Babu D, et al. (2004) Up-regulation of Flotillin-2 is associated with melanoma progression and modulates expression of the thrombin receptor protease activated receptor 1. Cancer Res. 64: 7361-7369. (Pubitemid 39372075)
7. Doherty SD, Prieto VG, George S, Hazarika P, Duvic M (2006) High flotillin-2 expression is associated with lymph node metastasis and Breslow depth in melanoma. Melanoma Res. 16: 461-463. (Pubitemid 44511228)
8. Wang X, Yang Q, Guo L, Li XH, Zhao XH, et al. (2013) Flotillin-2 is associated with breast cancer progression and poor survival outcomes. J Transl Med 11:190.
9. Zhu Z, Wang J, Sun Z, Sun X, Wang Z, et al. (2013) Flotillin2 expression correlates with HER2 levels and poor prognosis in gastric cancer. PLoS One 8:e62365.
10. Yang XY, Ren CP, Wang L, Li H, Jiang CJ, et al. (2005) Identification of differentially expressed genes in metastatic and non-metastatic nasopharyngeal carcinoma cells by suppression subtractive hybridization. Cell Oncol 27: 215-223. (Pubitemid 43086475)
11. Fan S, Ramalingam SS, Kauh J, Xu Z, Khuri FR, et al. (2009) Phosphorylated eukaryotic translation initiation factor 4 (eIF4E) is elevated in human cancer tissues. Cancer Biol Ther 8: 1463-1469.
12. Lang DM, Lommel S, Jung M, Ankerhold R, Petrausch B, et al. (1998) Identification of reggie-1 and reggie-2 as plasmamembrane-associated proteins which cocluster with activated GPI-anchored cell adhesion molecules in non-caveolar micropatches in neurons. J Neurobiol 37: 502-523. (Pubitemid 28549214)
13. Solis GP, Lüchtenborg AM, Katanaev VL (2013) Wnt secretion and gradient formation. Int J Mol Sci. 14: 5130-5145.
14. Ge L, Qi W, Wang LJ, Miao HH, Qu YX, et al. (2011) Flotillins play an essential role in Niemann-Pick C1-like 1-mediated cholesterol uptake. Proc Natl Acad Sci U S A 108: 551-556.
15. Solis GP, Schrock Y, Hülsbusch N, Wiechers M, Plattner H, et al. (2012) Reggies/flotillins regulate E-cadherin-mediated cell contact formation by affecting EGFR trafficking. Mol Biol Cell 23: 1812-1825.
16. Pan CC, Lu J, Yu JR, Chen P, Li W, et al. (2012) Challenges in the modification of the M1 stage of the TNM staging system for nasopharyngeal carcinoma: A study of 1027 cases and review of the literature. Exp Ther Med 4: 334-338.
17. Lee CC, Chu ST, Chou P, Lee CC, Chen LF (2008) The prognostic influence of prevertebral space involvement in nasopharyngeal carcinoma. Clin Otolaryngol. 33: 442-429.
18. Shen ZH, Chen XY, Chen J (2008) Impact of up-regulating Ezrin expression by Epstein-Barr virus latent membrane protein 1 on metastasis ability of nasopharyngeal carcinoma cells. Ai Zheng 27: 165-169.
19. Peng S, Fan S, Li X, Wang L, Liu H, et al. (2007) The expression of ezrin in NPC and its interaction with NGX6, a novel candidate suppressor. Cancer Sci 98: 341-349. (Pubitemid 46195604)
20. Peng SP, Li XL, Wang L, Ou-Yang J, Ma J, et al. (2006) The role of NGX6 and its deletion mutants in the proliferation, adhesion and migration of nasopharyngeal carcinoma 5-8F cells. Oncology 71: 273-881.
21. Hwang CF, Shiu LY, Su LJ, Yu-Fang Yin, Wang WS, et al. (2013) Oncogenic fibulin-5 promotes nasopharyngeal carcinoma cell metastasis through the FLJ10540/AKT pathway and correlates with poor prognosis. PLoS One 8: e84218.
22. Xuan SH, Zhou YG, Pan JQ, Zhu W, Xu P (2013) Overexpression of integrin av in the human nasopharyngeal carcinoma associated with metastasis and progression. Cancer Biomark 13(5): 323-328.
23. Pei XJ, Wu TT, Li B, Tian XY, Li Z, et al. (2013) Increased expression of macrophage migration inhibitory factor and DJ-1 contribute to cell invasion and metastasis of nasopharyngeal carcinoma. Int J Med Sci 11: 106-115.
24. Zheng J, Li J, Xu L, Xie G, Wen Q, et al. (2014) Phosphorylated Mnk1 and eIF4E Are Associated with Lymph Node Metastasis and Poor Prognosis of Nasopharyngeal Carcinoma. PLoS One 9: e89220.
25. Berger T, Ueda T, Arpaia E, Chio II, Shirdel EA, et al. (2013) Flotillin-2 deficiency leads to reduced lung metastases in a mouse breast cancer model. Oncogene 32: 4989-4994.
26. Xu L, Jiang Y, Zheng J, Xie G, Li J, et al. (2013) Aberrant expression of β-catenin and E-cadherin is correlated with poor prognosis of nasopharyngeal cancer. Hum Pathol 44: 1357-1364.
27. Bensouda Y, Kaikani W, Ahbeddou N, Rahhali R, Jabri M, et al. (2011) Treatment for metastatic nasopharyngeal carcinoma. Eur Ann Otorhinolaryngol Head Neck Dis 128: 79-85.
28. Lee AW, Poon YF, Foo W, Law SC, Cheung FK, et al. (1992) Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys 23: 261-270.